Can herbs provide a new generation of drugs for treating Alzheimer's disease?

[1]  D. Ferrari,et al.  Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.

[2]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[3]  J. Thome,et al.  Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. , 1996, Life sciences.

[4]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[5]  E. Perry,et al.  Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence. , 1998, Journal of alternative and complementary medicine.

[6]  L. Beckett,et al.  Vitamin E and Vitamin C Supplement Use and Risk of Incident Alzheimer Disease , 1998, Alzheimer disease and associated disorders.

[7]  Kee Chang Huang,et al.  The Pharmacology of Chinese Herbs , 1998 .

[8]  E. Perry,et al.  Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies , 1998, Journal of neurochemistry.

[9]  G. Siest,et al.  Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry , 1998, FEBS letters.

[10]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[11]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[12]  Y. Christen,et al.  Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. , 1999, Free radical biology & medicine.

[13]  E. Perry,et al.  Medicinal Plants and Alzheimer's Disease: from Ethnobotany to Phytotherapy ** , 1999, The Journal of pharmacy and pharmacology.

[14]  V. Glaser.  Billion-dollar market blossoms as botanicals take root , 1999, Nature Biotechnology.

[15]  R. Quirion,et al.  The Ginkgo biloba Extract (EGb 761) Protects and Rescues Hippocampal Cells Against Nitric Oxide‐Induced Toxicity , 2000, Journal of neurochemistry.

[16]  L. Zhou,et al.  Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. , 2000, The Journal of pharmacology and experimental therapeutics.

[17]  S. K. Ghosal,et al.  Antioxidant activity ofBacopa monniera in rat frontal cortex, striatum and hippocampus , 2000, Phytotherapy research : PTR.

[18]  Y. Christen,et al.  The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid , 2000 .

[19]  Ming D. Li,et al.  Nicotine Enhances the Biosynthesis and Secretion of Transthyretin from the Choroid Plexus in Rats: Implications for β-Amyloid Formation , 2000, The Journal of Neuroscience.

[20]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[21]  R. Yu,et al.  Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis , 2000, Archives of pharmacal research.

[22]  R. K. Gordon,et al.  The NMDA receptor ion channel: a site for binding of huperzine A , 2001, Journal of applied toxicology : JAT.

[23]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[24]  J. Joseph,et al.  A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. , 2001, Free radical biology & medicine.

[25]  N. Perry,et al.  In‐vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's disease , 2001, The Journal of pharmacy and pharmacology.

[26]  N. Krebs.  Bioavailability of dietary supplements and impact of physiologic state: infants, children and adolescents. , 2001, The Journal of nutrition.

[27]  Claire Copland,et al.  Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial , 2001, International journal of geriatric psychiatry.

[28]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[29]  G. Hu,et al.  Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons , 2001, Neuroscience.

[30]  K. Iverfeldt,et al.  Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576 , 2001, Neuroscience Letters.

[31]  D. Butterfield,et al.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.

[32]  V. Papadopoulos,et al.  The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands , 2001, Brain Research.

[33]  G. Cole,et al.  The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse , 2001, The Journal of Neuroscience.

[34]  G L Snyder,et al.  Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? , 2001, The Journal of biological chemistry.

[35]  S. Suh,et al.  The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons , 2001 .

[36]  P. Schultz,et al.  The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. van Nood,et al.  Flavonoids: a review of probable mechanisms of action and potential applications. , 2001, The American journal of clinical nutrition.

[38]  E. Williamson,et al.  Synergy and other interactions in phytomedicines. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[39]  David J. Cummins,et al.  Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Morelli,et al.  Alternative therapies for traditional disease states: menopause. , 2002, American family physician.

[41]  E. Perry,et al.  Salvia lavandulaefolia essential oil inhibits cholinesterase in vivo. , 2002, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[42]  J. Buccafusco,et al.  Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. , 2002, Life sciences.

[43]  D. Wallace,et al.  Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. , 2002, Cellular and molecular biology.

[44]  Bin Liu,et al.  Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species , 2002 .

[45]  D. Bennett,et al.  Dietary Intake of Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a Biracial Community Study , 2022 .

[46]  Zhixin Wu,et al.  Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. , 2002, Cellular and molecular biology.

[47]  D. Schenk.  Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning , 2002, Nature Reviews Neuroscience.

[48]  P. Fattoretti,et al.  Chronic administration of EGb 761 modulates synaptic and mitochondrial plasticity in adult vitamin E-deficient rats. , 2002, Cellular and molecular biology.

[49]  Q. Peng,et al.  Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[50]  P. Solomon,et al.  Ginkgo for memory enhancement: a randomized controlled trial. , 2002, JAMA.

[51]  E. Perry,et al.  Chronic nicotine treatment reduces β‐amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw) , 2002, Journal of neurochemistry.

[52]  C. Holmes,et al.  Genotype and phenotype in Alzheimer's disease , 2002, British Journal of Psychiatry.

[53]  Paul F. Smith,et al.  The CNS effects of Ginkgo biloba extracts and ginkgolide B , 2002, Progress in Neurobiology.

[54]  A. A. Clair,et al.  Influence of aromatherapy on medication administration to residential-care residents with dementia and behavioral challenges , 2002, American journal of Alzheimer's disease and other dementias.

[55]  R. Quirion,et al.  EGb 761 is a neuroprotective agent against beta-amyloid toxicity. , 2002, Cellular and molecular biology.

[56]  M. Grundman,et al.  Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.

[57]  B. Winblad,et al.  Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice , 2002, Journal of Neuroimmunology.

[58]  E. Perry,et al.  Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa. , 2002, The Journal of clinical psychiatry.

[59]  P. Butko,et al.  Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Holtzman,et al.  Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease , 2002, Science.

[61]  G. Hu,et al.  Spermidine antagonizes the inhibitory effect of huperzine A on [3H]dizocilpine (MK-801) binding in synaptic membrane of rat cerebral cortex , 2002, Neuroscience Letters.

[62]  C. Codina,et al.  Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. , 2002, Life sciences.

[63]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[64]  I. Raskin,et al.  Plants and human health in the twenty-first century. , 2002, Trends in biotechnology.

[65]  C. Holmes,et al.  Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study , 2002, International journal of geriatric psychiatry.

[66]  Y. Gupta,et al.  Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. , 2002, Life sciences.

[67]  So-Young Park,et al.  Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. , 2002, Journal of natural products.

[68]  R. Rishi.  Phytoestrogens in health and illness , 2002 .

[69]  H. Cho,et al.  Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells. , 2002, Molecules and cells.

[70]  N. Perry,et al.  Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders , 2003, Phytotherapy research : PTR.

[71]  B. Vellas,et al.  Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[72]  J. Stephenson.  PEP talk: treating nonoccupational HIV exposure. , 2003, Journal of the American Medical Association (JAMA).

[73]  R. Martins,et al.  Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. , 2003, Free radical biology & medicine.

[74]  Zhang-Jin Zhang,et al.  The herbal medicine Dipsacus asper wall extract reduces the cognitive deficits and overexpression of beta-amyloid protein induced by aluminum exposure. , 2003, Life sciences.

[75]  F. Achike,et al.  Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway , 2003, Clinical and experimental pharmacology & physiology.

[76]  C. Finch,et al.  Self-assembly of Aβ1-42 into globular neurotoxins , 2003 .

[77]  C. Rice-Evans,et al.  Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. , 2003, The Biochemical journal.

[78]  F. Fang,et al.  Involvement of CDK4, pRB, and E2F1 in ginsenoside Rg1 protecting rat cortical neurons from beta-amyloid-induced apoptosis. , 2003, Acta pharmacologica Sinica.

[79]  B. Tesch.  Herbs commonly used by women: an evidence-based review. , 2003, American Journal of Obstetrics and Gynecology.

[80]  B. Ahlemeyer,et al.  Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s Disease , 2003, Pharmacopsychiatry.

[81]  E. Perry,et al.  Salvia lavandulaefolia (Spanish Sage) enhances memory in healthy young volunteers , 2003, Pharmacology Biochemistry and Behavior.

[82]  Serge Gauthier,et al.  Alzheimer's disease: the pharmacological pathway , 2003, Fundamental & clinical pharmacology.

[83]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[84]  Mohammad Reza Mohammadi,et al.  Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial , 2003, Journal of neurology, neurosurgery, and psychiatry.

[85]  R. Stackman,et al.  Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment , 2003, Experimental Neurology.

[86]  Hong-Zhuan Chen,et al.  Differentiating effects of anisodamine on cognitive amelioration and peripheral muscarinic side effects induced by pilocarpine in mice , 2003, Neuroscience Letters.

[87]  P. Knipschild,et al.  Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.

[88]  J. V. Smith,et al.  Studies on molecular mechanisms of Ginkgo biloba extract , 2004, Applied Microbiology and Biotechnology.

[89]  M. Robin,et al.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells , 2003, The Journal of cell biology.

[90]  A. Russo,et al.  Red wine micronutrients as protective agents in Alzheimer-like induced insult. , 2003, Life sciences.

[91]  P. Bars.  Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles , 2003 .

[92]  P. Houghton,et al.  Plants and the central nervous system , 2003, Pharmacology Biochemistry and Behavior.

[93]  E. Carlini.  Plants and the central nervous system , 2003, Pharmacology Biochemistry and Behavior.

[94]  W. Keung,et al.  Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-β peptide , 2003, Brain Research.

[95]  Y. Gupta,et al.  Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats , 2003, Clinical and experimental pharmacology & physiology.

[96]  Yuan-Ping Pang,et al.  Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity. , 2003, Journal of the American Chemical Society.

[97]  Mohammad Reza Mohammadi,et al.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo‐controlled trial , 2003, Journal of clinical pharmacy and therapeutics.

[98]  E. Perry,et al.  Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial , 2003, Pharmacology Biochemistry and Behavior.

[99]  H. Weiner,et al.  Immunotherapeutic Approaches to Alzheimer's Disease , 2003, Science.

[100]  P. Houghton,et al.  Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function , 2003, Pharmacology Biochemistry and Behavior.

[101]  O. Krishtal,et al.  Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. , 2003, Pharmacopsychiatry.

[102]  R. Acquaviva,et al.  Nitric oxide-related toxicity in cultured astrocytes: effect of Bacopa monniera. , 2003, Life sciences.

[103]  D. S. Nunes,et al.  Ptychopetalum olacoides, a traditional Amazonian “nerve tonic”, possesses anticholinesterase activity , 2003, Pharmacology, Biochemistry and Behavior.

[104]  Y. Surh,et al.  Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death ☆ , 2003 .

[105]  L. Launer.  Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next? , 2003, JAMA.

[106]  V. Schulz.  Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[107]  S. Leutner,et al.  Effects of EGb 761® Ginkgo biloba Extract on Mitochondrial Function and Oxidative Stress , 2003, Pharmacopsychiatry.

[108]  Effect of Ginkgo biloba (EGb 761) on differential gene expression. , 2003, Pharmacopsychiatry.

[109]  A. Spector,et al.  Aroma therapy for dementia. , 2003, The Cochrane database of systematic reviews.

[110]  A. Zangara.  The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease , 2003, Pharmacology Biochemistry and Behavior.

[111]  S. Kanowski,et al.  Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial. , 2003, Pharmacopsychiatry.

[112]  Chieh-fu Chen,et al.  The extracts from Nelumbo Nucifera suppress cell cycle progression, cytokine genes expression, and cell proliferation in human peripheral blood mononuclear cells. , 2004, Life sciences.

[113]  B. Shukitt-Hale,et al.  Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. , 2004, Free radical biology & medicine.

[114]  Han Yan,et al.  Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-α in intracerebroventricular β-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells , 2004, Neuroscience Letters.

[115]  P. Houghton,et al.  Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. , 2004, Planta medica.

[116]  Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-protein-treated rats determined by an improved HPLC. , 2004, Acta pharmacologica Sinica.

[117]  E. Okello,et al.  Butyryl‐ and acetyl‐cholinesterase inhibitory activities in essential oils of Salvia species and their constituents , 2004, Phytotherapy research : PTR.

[118]  E. Ongini,et al.  Non‐steroidal anti‐inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action , 2004, Journal of neurochemistry.

[119]  P. S. St George-Hyslop,et al.  Immunotherapy for Alzheimer's disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[120]  Y. Christen,et al.  Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts , 2004, Neurobiology of Disease.

[121]  H. Arai,et al.  Effect of kami-untan-to on the impairment of learning and memory induced by thiamine-deficient feeding in mice , 2004, Neuroscience.

[122]  Jason Brandt,et al.  A controlled trial of aromatherapy for agitation in nursing home patients with dementia. , 2004, Journal of alternative and complementary medicine.

[123]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[124]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[125]  Zheng Feng,et al.  Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease , 2004, Journal of pineal research.

[126]  M. Meselhy,et al.  Aβ(25–35)-Induced Memory Impairment, Axonal Atrophy, and Synaptic Loss are Ameliorated by M1, A Metabolite of Protopanaxadiol-Type Saponins , 2004, Neuropsychopharmacology.

[127]  Deborah Gustafson,et al.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.

[128]  V. Kalra,et al.  Curcumin, the active constituent of turmeric, inhibits amyloid peptide‐induced cytochemokine gene expression and CCR5‐mediated chemotaxis of THP‐1 monocytes by modulating early growth response‐1 transcription factor , 2004, Journal of neurochemistry.

[129]  E. Perry,et al.  Nicotine reduces Aβ in the brain and cerebral vessels of APPsw mice , 2004, The European journal of neuroscience.

[130]  Byung-Soo Koo,et al.  A water extract of Curcuma longa L. (Zingiberaceae) rescues PC12 cell death caused by pyrogallol or hypoxia/reoxygenation and attenuates hydrogen peroxide induced injury in PC12 cells. , 2004, Life sciences.

[131]  J. Quinn,et al.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. , 2004, Human molecular genetics.

[132]  J. Raber.  Androgens, apoE, and Alzheimer's disease. , 2004, Science of aging knowledge environment : SAGE KE.

[133]  Kenjiro Ono,et al.  Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.

[134]  C. Rice-Evans,et al.  Flavonoids: antioxidants or signalling molecules? , 2004, Free radical biology & medicine.

[135]  A. Periclou,et al.  Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil , 2004, The Annals of pharmacotherapy.

[136]  F. LaFerla,et al.  Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau , 2004 .

[137]  Y. Liang,et al.  Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats , 2004, Neuroscience Letters.

[138]  Kinzo Matsumoto,et al.  Evaluation of the nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivative. , 2004, Biological & pharmaceutical bulletin.

[139]  Cheorl-Ho Kim,et al.  Attenuating effect of a traditional korean formulation, Paeng‐Jo‐Yeon‐Nyeon‐Baek‐Ja‐In‐Hwan (PJBH), on hydrogen peroxide‐induced injury in PC12 cells , 2004, Phytotherapy research : PTR.

[140]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[141]  Dai Zhang,et al.  Tenuigenin treatment decreases secretion of the Alzheimer’s disease amyloid β-protein in cultured cells , 2004, Neuroscience Letters.

[142]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[143]  J. Wuu,et al.  Reduction of cortical TrkA but not p75NTR protein in early‐stage Alzheimer's disease , 2004, Annals of neurology.

[144]  William M. Mauck,et al.  Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice , 2004, Journal of neurochemistry.

[145]  M. Salmona,et al.  Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42 , 2004, Journal of Neuroinflammation.

[146]  M. Beal,et al.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[147]  Mujo Kim,et al.  Effects of Green Tea Polyphenol on Cognitive and Acetylcholinesterase Activities , 2004, Bioscience, biotechnology, and biochemistry.

[148]  Ki Yong Lee,et al.  ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice. , 2005, Life sciences.

[149]  M. Luca,et al.  Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients , 2005, Neurobiology of Disease.

[150]  H. Bae,et al.  Effects of Yukmijihwang-tang derivatives (YMJd), a memory enhancing herbal extract, on the gene-expression profile in the rat hippocampus. , 2005, Biological & pharmaceutical bulletin.

[151]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[152]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.

[153]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.

[154]  G. Laviola,et al.  Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer’s disease , 2005, Behavioural Brain Research.

[155]  M. Roth,et al.  The Liver X Receptor Ligand T0901317 Decreases Amyloid β Production in Vitro and in a Mouse Model of Alzheimer's Disease* , 2004, Journal of Biological Chemistry.

[156]  J. Wands,et al.  Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[157]  Hiroaki Kazui,et al.  Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? , 2005, The American journal of psychiatry.

[158]  R. Tanzi,et al.  Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.

[159]  J. McGraw,et al.  Deer Browsing and Population Viability of a Forest Understory Plant , 2005, Science.

[160]  E. Ongini,et al.  Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease , 2005, Brain Research Reviews.

[161]  Dominic M. Walsh,et al.  Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation , 2005, The Journal of Neuroscience.

[162]  J. Moss,et al.  Herbal medicines and perioperative care. , 2001, Anesthesiology.

[163]  M. Folstein,et al.  Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis , 2006, Neurobiology of Aging.

[164]  P. Reddy,et al.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease , 2007, NeuroMolecular Medicine.